Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is a circular discussion. My original point has been made - awaiting regulatory approval. No spin, just the facts.
I had an interesting vc with the individual this afternoon who walked me through some of the crazy stuff going on in the market, which led to my question about the SCRC short interest. The last time he checked, there was no short interest. But now, depending on whether you rely on NASDAQ, Interactive Brokers, shortsqueeze.com or some other service, the reported short interest is below 50,000 shares. Though this is a tiny fraction of the total OS, he said several traders can work in concert to borrow against the shares at the same time in an effort to "bid pin" the stock and move the sp down. He said it is much easier for them to move the sp down than up, because it is very easy for them to spread fear and cause the typical retail long to sell out of fear. These traders can do this on a daily basis and make good money sucking liquidity out of the market. He has no idea if it's happening here, but did walk me through many major exchange stocks that continue to beat earnings quarter after quarter, but have been heavy manipulated and worked down to 52-week lows over the past year. Perhaps the folks over on the stock ethics board could take this on as a project and actually to the average retail investor some good for a change.
Your essay response shifting the issue does not change the underlying facts of my point. That is, there are facts expressed in the public domain to support that the delay for RapiMeds is being caused by red tape, not a lack of retail interest.
Thanks, Rocky. I am optimistic as well though I really don't believe there is much if any shorting going on here. One of my good friends, and the most successful and knowledgeable person I know in this field tells me this stock is not even "shortable", new word. I know little about shorting, but I'll take his word for it. That said, he also mentioned some spooky stuff about dark pools, high frequency trading, and good old fashioned manipulation, but I'll leave that to the experts. The bottom line is the vastly improved fundamentals are not even close to being reflected in the current share price.
Take care.
@CHP: I'm finally starting to dig into the Q2 report and found something interesting related the following comment you made:
@ Kaleb: I appreciate the analysis. I look forward to digging into the fins soon to check your math. Regardless, one thing appears to be certain, Scrips has made significant progress and will likely report positive earnings in Q3. And if your math and assumptions are correct, it appears SCRC threw the kitchen sink of expenses in to make an even better than expected Q3.
Good luck to all of the patient longs here!
Bsav88atty
Good analysis, Rocky. Thanks for sharing.
@CHP: You make it hard for a fella to stay away from this board. I have not yet had time to review the fins and will not commnet on your dissection of each page. I will, however, address your well-written but completely incorrect opinions about Sean Fitzgibbons. Simply put, he is neither employed by SCRC nor is he now or has he ever been a paid promoter. As much as I'm sure he could use an extra $115K per year, he is sticking with his current situation. Whether you believe me or not is completely your choice.
Respectfully,
Bsav88atty
Yes, Tutter, there are two actions pending: one in the CA state court system (filed by Ironridge) and the other filed in the federal court system (filed by ScripsAmerica, Inc.).
What I find more interesting is that the order cited today as "news" from Ironridge via Reuters was entered by the CA Superior Court judge on May 6, 2014, over three months ago. Link to order referenced in today's "news"report here: http://www.accesswire.com/uploads/Order-in-Favor-of-Ironridge-Global.pdf.
Of course, Scrips previously reported this order in prior filings and also reported that it has appealed this order. I have yet to see a ruling on this appeal. Moreover, I have not seen any orders from the lawsuit that Scrips filed in the CA federal district court.
Any opinions on why a May 6 order was determined by IR to be newsworthy today? I have my thoughts, but I will keep them to myself and go crawl back into my corner for another few months.
Good luck to all the longs here!
FWIW, I agree this is no big deal, just a ruling on a privileges issue. I'm sure ATRS has more than enough to support its claims.
I just figured out why the huge spike in the total OS. Here you are:
HOUSTON, TX--(Marketwired - Feb 5, 2014) - Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) ("Dewmar" or "Company") announced today growth initiatives for the brand management company, as well as its flagship product, Lean Slow Motion Potion, ("Brand") which is expected to achieve a 300% increase during Q1-2014 compared to previous quarter as the Company prepares to fulfill a significant number of outstanding purchase orders for Lean from distributors and refill displays at Walmart.
Most importantly, for Dewmar and its shareholders, the company has successfully managed through a series of 'toxic' financing facilities with two New York City investment groups that converted over 1.27 billion shares which ultimately placed downward pressure on the company's market price, dropping it from a high of $0.50. Dewmar is proud to announce that there are no additional outstanding toxic financing facilities that would allow debtors to convert any more Company stock as of this writing.
Additionally, Dewmar has entered into strong relationships with new bottlers and warehousing facilities to avoid issues faced in 2013 pertaining to higher production run costs and unsuspecting storage issues that resulted in significant inventory losses this past summer. Lastly, Dewmar has deflected several frivolous lawsuits filed by one disgruntled competitor and their cohorts. With these accomplishments, a strong leading Brand and quality channel partners, Dewmar is well positioned for growth in 2014.
Lean's entrance into shelf space at Walmart is a significant achievement, as is the product cold vault displays at Walgreens in Des Moines and Omaha, cultivated by long-standing independent distributors of Lean based in Nebraska. Dewmar plans to significantly expand upon these existing accounts as the year progresses. Further, the 2014 Lean Slow Motion Potion rebranding project with an aim to broaden Brand appeal across a wider consumer demographic is anticipated to have a significant effect on an increase in sales.
"Lean has separated itself from the conversation of 'fly by night' relaxation brands that have come and gone over the years," said Marco Moran, CEO of Dewmar. "Our patience has paid off. We are one of the few remaining companies in the relaxation space that's well positioned for growth; in fact, in 2008 the category consisted of over 30 brands which has dwindled down to 5 now who capture the majority of the U.S. market. Moreover, our ability to seek out proper distribution channels and cultivate strong relationships with distributors has resulted in significant loyalty to the brand from both consumers and the beverage industry itself. In 2014, Dewmar anticipates expansion into newer regions of the country, by taking advantage of government contracts via SAMS registration and by adding skilled sales professionals to our staff. The company plans to gain access to a variety of international markets through newly cultivated relationships. It is essential that Dewmar continue to grow strategically, building confidence in old markets while making introductions into new sales channels."
Additionally, due to the skyrocketing industrial hemp and medical marijuana industry, Dewmar also announces plans to aggressively seek within this emerging space numerous partnerships, joint ventures, exclusive product licensing agreements and/or acquisitions of product lines that would add value to the Company's bottom line. Dewmar is discussing the pursuit in development of new food/beverage products that contain hemp oil extracts and other cannabinoid-related ingredients that qualify to be sold in all 50 states.
The Company has also increased the number of authorized shares to 4.5 billion, the purpose being to have available, only if necessary, some additional restricted shares to be utilized as part of the acquisition of profitable entities or for the exchange of services that would be extremely beneficial toward the growth of Dewmar.
Dewmar proudly announces that due to a massive response from investors in DEWM stock volume and price increases following the December 11, 2013 press release announcing Lean Slow Motion Potion's presence in Walmart, an agent of the Financial Industry Regulatory Authority (FINRA) conducted a routine 30 minute interview with the CEO about Dewmar's history, business practices and in-depth relationship with Walmart. FINRA is dedicated to investor protection and market integrity through effective and efficient regulation of the securities industry. Dewmar immediately complied by providing all such requested information as to be in full and immediate compliance.
Dewmar prides itself in working hard to ensure the long term success of the Company and seeks to comply with all SEC rules to report material events accordingly. As such, all investors will be responded to in a public forum by way of press release or public recording, no individual emails or calls will be responded to with regards to any Company updates.
Not sure what you mean about "antics". But just in case you are unable to access the intro portion of this board, here is the share structure that one of the mods posted. And for the record, I'm not a basher and I cannot stand Asher, Ironridge and the other toxic financiers who profit while destroying small companies.
DEWM Security Details
Share Structure
Shares Outstanding
2,364,913,513
a/o Mar 12, 2014
Float
~2,000,000,000
a/o Dec 26, 2013
Authorized Shares
4,500,000,000
a/o Dec 26, 2013
CONTACT:
Dewmar International BMC, Inc.
www.DewmarInternational.com
1-877-SIP-LEAN or 1-877-747-5326.
InvestorRelations@DewmarInternational.com
FischTank PR
http://www.fischtankpr.com/
Eric Fischgrund
For media inquiries, please e-mail eric@FischTankPR.com
http://www.huffingtonpost.com/eric-fischgrund/
Not trying to post b.s. here. Did you review the numbers that one of the mods pasted in the intro of this board? If not just check it out. I promise I'm not making up numbers. Moreover, check out the Q3 filing, the number of shares outstanding at the end of Q3, and then read the subsequent events section in that same report where DEWM issued millions of shares to Asher from 9/31/13 to the date of the report in November. Just that total alone takes the OS to well over 600 million.
Also, below is pasted directly from the OTC website:
DEWM Security Details
Share Structure
Market Value1 $8,277,197 a/o Jun 27, 2014
Shares Outstanding 2,364,913,513 a/o Mar 31, 2014
Float 595,745,696 a/o Dec 13, 2013
Authorized Shares 2,500,000,000 a/o Apr 01, 2013
Par Value 0.001
Shareholders
Shareholders of Record 201 a/o Dec 13, 2013
Short Selling Data
Short Interest 14,882 (-99.5%)
Jun 13, 2014
Significant Failures to Deliver No
Transfer Agent(s)
Empire Stock Transfer Inc.
If you don't believe me, here's the link, which I thought you provided a couple hours ago: http://www.otcmarkets.com/stock/DEWM/profile. So, you see you are absolutely correct on the float total. But I'm not talking about the float. And I don't have L2.
I'm copying data from the intro here and the OTC site you posted. I'm not concerned about the float from a valuation perspective, I'm concerned about the total outstanding shares, a much larger number that is used to determine market cap and most places, the price of a stock. If you see a more accurate total OS, please share. That will make a huge difference in my opinion. Thanks.
I'm not trying bash, just share my thoughts based on the filings and help folks who do not have time to read the fins or simply choose not to revenue them understand more about the company's fundamentals. Typically, the amount of outstanding shares and whether a company is producing earnings are key elements to determining a company's value. My apologies if any of my posts appear to be bashing, I will not object to the mods deleting them. Good luck to all the longs here.
If this information is reflected in the fins, the company's revs in FY13 were about $1.2 million. Considering the same reported operating expenses as FY12 of $4.4 million, DEWM will report a net loss of approximately $3.2 million. But it does appear from the Q3 report that OPEX decreased and would support a smaller net loss. For example, extrapolating the numbers using the data from the first 9 months, assuming $1.2 million revs, would yield a net loss of approximately $800K. This would be a definite improvement over the big loss in 2012, but in my opinion, not enough of an improvement to justify the current market cap.
As for the 562% increase over FY13 Q3, the company reported about $52K in the third quarter last year. Though this PR was confusing regarding which quarter was 562% higher than the Q3 revs, I assume DEWM meant Q4, which would have been about $302K. But this would not make sense considering revenues for the first 9 months of FY14 were about $232K, as this would yield annual net revs of only $534K versus the $1.2 million estimate based on the 124% announced increase over FY12 net revs. Frankly, I have no idea what the 562% is supposed to represent. Can anyone help here?
One interesting factor that should have all the shareholders concerned here is that during this alleged period of increased revenues, the total outstanding shares increased from about 520 million at the end of Q3 to about 2.4 billion shares by 3/31/14. I am curious to learn how much more dilution has occurred since March. If the company is diluting at the same rate it did between 9/31/13 and 3/31/14 (362% increase in total OS), the total OS would be about 3.34 billion shares. I would not be surprised to see an announcement of an upcoming proposal for a massive reverse split (e.g., 50:1).
So while these PRs and forward-looking statements are nice to read, and while it appears the company is improving, in my humble opinion, it has a long way to go before justifying even the current sp. Perhaps the fins will shed some light on the company's progress. But until I see evidence the dilution train has significantly slowed, that the company has a good shot at succeeding and becoming profitable, and I see an sp that is more in line with that probable success, I'll be watching from the sidelines. I wish the dedicated longs here the best of luck with this one. I'm not a trader and I stink at timing short-term price movements. I'm certain there's money to be made trading this stock.
Understood, probably best for the longs here that Asher sold all of their shares. Does Ironridge own any?
How many shares did Asher previously own?
Thanks, Dallas.
I simply copied it from the intro for this board and pasted it here. I assume one of the mods inserted it. Perhaps the mods should update the intro to this board.
To be fair to you, here is the reported share structure per your link.
DEWM Security Details
Share Structure
Market Value1 $8,277,197 a/o Jun 27, 2014
Shares Outstanding 2,364,913,513 a/o Mar 31, 2014
Float 595,745,696 a/o Dec 13, 2013
Authorized Shares 2,500,000,000 a/o Apr 01, 2013
Par Value 0.001
Shareholders
Shareholders of Record 201 a/o Dec 13, 2013
Short Selling Data
Short Interest 14,882 (-99.5%)
Jun 13, 2014
Significant Failures to Deliver No
Transfer Agent(s)
Empire Stock Transfer Inc.
Other than the increase in the AS on the intro to 4.5 billion, the OS is virtually identical. Did I miss something? Has the company issued additional shares since March 31?
Thanks!
Interesting. The fins were due on 4/15, correct? And the Q1 fins on or about 5/15, I assume. This must be one heck of an audit. Did they change auditors as well? Any educated opinions on why the audit is taking so long? I'd also appreciate thoughts on my other questions (e.g., top reasons to buy or watch from the sidelines, why the amazing pop in the sp earlier this year, why the steady and continuous fall for the past several mos). It also appears this was heavily promoted. Indeed, simply check out the posting on iHub over the past year and take note of when the volume of the posts here significantly increase. Interesting.
Over the past few months I've received several PMs from different folks making strongly-worded pitches to buy DEWM. Today I started to take a peek at this company and just wanted to pose a few questions to the posters here with the most knowledge of this company. First, per the intro on this board, the company's share structure is as follows:
Shares Outstanding
2,364,913,513
a/o Mar 12, 2014
Float
~2,000,000,000
a/o Dec 26, 2013
Authorized Shares
4,500,000,000
a/o Dec 26, 2013
I also did a quick search for the SEC filings and noticed the company is not only delinquent in filing its 10Q for the year, but it has yet to file its 10K for 2013. Does DEWM operate on a typical calendar year or some other fiscal calendar? Has the company provided any statements addressing their significant delinquency with the SEC? Per the past finanicial report, it appears the company reported a net loss of about $4 million. Is this correct?
Also, has the company updated its OS total? With about 2.4 billion shares outstanding, the company must deliver net earnings of about $100 million to justify a sp above $.50. Any ideas on whether the company is currently profitable, buring through cash or continuing to massively dilute?
Looking at the chart, I noticed an unbelievable rise in the sp at the beginning of the year on extremely heavy volume that exponentially exceeded the company's prior volume. What happened during this big runnup? I couldn't find anything in the filings to justify this amazing increase. Since this rise, however, it appears the stock has entered a sustained and painful downtrend. Why the slow and steady sell off? Any opinions on a bottom? I'm not a techinical trader, and it would be helpful to read opinions from the more technically savvy on this board.
It would also be helpful to see the top five reasons to buy DEWM now or the top five reasons to move on to a different opportunity.
Thanks!
Bsav88atty
Diamondcutter - Many thanks, my friend!
You have taken on a worthy task. Please ping me if you need any help. And on behalf of virtually all the shareholders, please allow me to wish you the best of luck and much success!
BSAV
Great pick up, Jab!
Wow, DC, I'm not touching that one with a 50-foot pole. Why don't you say how you really feel.
By the way, if you're looking for more forensic work, I sure could use your help on that other board!
@Chicag0 - You said as follows:
Well, there you are. Watch out for another rinse and repeat there. No disrespect to Paul, but geeeesh, no question he will have his work cut out for him over there. Best of luck!
Sad, but true. Meanwhile, Scrips is improving by the day.
Thanks for posting, TD. I believe folks who took advantage of the drop in sp today will be glad they did. Oftentimes, these reactions are overblown and the price declines are short lived. Anyone here remember the LibiGel flash crash? Of course today's dip was nothing close to that, but I do expect a quick recovery. Good luck!
Wow, DC, that's just about all I can say, Wow!
I'm not following that other company, but 2.6 billion total outstanding shares...no thank you! And people complain about the massive dillution with the company where I have spent the majority of my time, which is likely cash flow positive and about a quarter away from recording a net profit. Sheeeesh!
If Paul thinks there is any chance with $ACTC, he should push for a large reverse split (e.g., 1:30).
ATRS will recover from today's news.
Thanks, Luvgrowth. It would be tough to pass on the Advanced Cell Tech opportunity, over $500K salary plus 30 million an options. Good luck to Paul, ATRS will be fine.